Your browser doesn't support javascript.
loading
Ligand Identification for Orphan MHC-Agnostic T-Cell Receptors by Whole Genome CRISPR-Cas9 Screening.
Crowther, Michael D; Legut, Mateusz; Sewell, Andrew K.
Afiliación
  • Crowther MD; Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK.
  • Legut M; National Center for Cancer Immune Therapy, Herlev, Denmark.
  • Sewell AK; Division of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK.
Methods Mol Biol ; 2574: 3-14, 2022.
Article en En | MEDLINE | ID: mdl-36087195
ABSTRACT
Killer T-cells play important roles in immunity to infection and cancer by detecting intracellular anomalies at the cell surface and destroying the cells that bear them. Conventional killer T-cells scan the intracellular proteome by sampling peptides presented at the cell surface by major histocompatibility complex (MHC) molecules. It is becoming apparent that some T-cells can also respond to pathogens and neoplasms by sensing intracellular changes through molecules other than MHC. We describe an unbiased methodology for T-cell receptor ligand discovery that requires no a priori knowledge regarding the nature of the antigen.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Sistemas CRISPR-Cas Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Sistemas CRISPR-Cas Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Año: 2022 Tipo del documento: Article